Table 2: Primary and secondary outcomes: adjusted regression coefficient or odds
ratio for electronic insulin protocol group to historical control group to
historical control group.
| 
   Outcome  | 
  
   Control
  group  (N
  = 87)  | 
  
   Study
  group  (N = 136)  | 
  
   Adjusteda regression coefficient or odds
  ratio (95% Cl)  | 
  
   p  | 
  
  |
| 
   Mean
  blood glucose during the first 120 hours  | 
  
      | 
  
      | 
  
      | 
  
      | 
  
  |
| 
   Mean
  blood glucose (mmol/L)  | 
  
   8.7  | 
  
   8.65  | 
  
   -0.08
  (-0.61, 0.46)b  | 
  
   0.776  | 
  
  |
| 
   Glycemic
  range during the first 120 hours  | 
  
      | 
  
      | 
  
      | 
  
      | 
  
  |
| 
   Hyperglycemic
  range ( > 10.0 mmol/L)  | 
  
   311
  (-28.4%)  | 
  
   572
  (-25.8%)  | 
  
   -2.85
  (-9.79, 4.09)b  | 
  
   0.419  | 
  
  |
| 
   Hypoglycemic
  range ( < 4.0 mmol/L  | 
  
   16
  (1.5%)  | 
  
   28
  (1.26%)  | 
  
   -0.75
  (-1.74, 0.24)b  | 
  
   0.138  | 
  
  |
| 
   Glucose
  variability during the first 120 hours  | 
  
      | 
  
      | 
  
      | 
  
      | 
  
  |
| 
   Variability
  during the first 120 hours  | 
  
   8.75  | 
  
   6.38  | 
  
   -2.63
  (-4.93, -0.33)b  | 
  
   0.025  | 
  
  |
| 
   Hypoglycemia
  during the first 120 hours  | 
  
      | 
  
      | 
  
      | 
  
      | 
  
  |
| 
   Hypoglycemia
  ( < 2.9 mmol/L) during the first 120 hours  | 
  
   16
  (1.5%)  | 
  
   28
  (1.26)  | 
  
   0.42
  (0.14, 1.25)c  | 
  
   0.12  | 
  
  |
| 
   Hospital
  outcomes  | 
  
      | 
  
      | 
  
      | 
  
      | 
  
  |
| 
   Ward
  length of stay (days)  | 
  
   9.6  | 
  
   11.1  | 
  
   0.26
  (-2.32, 2.84)b  | 
  
   0.842  | 
  
  |
| 
   In-hospital
  mortality  | 
  
   9  | 
  
   4  | 
  
   0.14
  (0.03, 0.64)c  | 
  
   0.011  | 
  
  |
| 
   Transfer
  to ICU  | 
  
   7  | 
  
   2  | 
  
   0.13
  (0.02, 0.85)c  | 
  
   0.034  | 
  
  
aAdjusted for age, diabetes type, main hospital diagnosis (LRTI or
acute cardiac condition), and chronic therapy at admission (metformin, insulin)b
Adjusted regression coefficientc Adjusted
regression coefficient